Assessment of transcriptional activity of Borrelia burgdorferi and host cytokine genes during early and late infection in a mouse model

Vector-Borne and Zoonotic Diseases

Volumn 13, Issue 10, 2013, Pages 694-711

  Hodzic, Emir ^a   Feng, Sunlian ^a   Barthold, Stephen W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Borrelia burgdorferi; Cytokine; Low density array; Mouse; Transcription

Indexed keywords

COLICIN V; COMPLEMENTARY DNA; CYTOKINE; DECORIN BINDING PROTEIN A; FLAGELLIN B; GAMMA INTERFERON; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOSAMINOGLYCAN BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; OUTER SURFACE PROTEIN A; OUTER SURFACE PROTEIN C; PROTEIN; RECA PROTEIN; RNA 18S; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; CHEMOKINE;

ANIMAL EXPERIMENT; ARTICLE; BORRELIA BURGDORFERI; DNA METABOLISM; DOWN REGULATION; GENE AMPLIFICATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; IMMUNITY; LYME DISEASE; MOUSE; MUSCLE TISSUE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; ANIMAL; C3H MOUSE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; GERMFREE ANIMAL; HEART; HOST PATHOGEN INTERACTION; IMMUNOLOGY; JOINT; MICROBIOLOGY; MOLECULAR GENETICS; MUSCLE; PHYSIOLOGY;

BORRELIA BURGDORFERI; MAMMALIA; MUS;

ANIMALS; BACTERIAL PROTEINS; BORRELIA BURGDORFERI; CHEMOKINES; CYTOKINES; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, BACTERIAL; HEART; HOST-PATHOGEN INTERACTIONS; JOINTS; LYME DISEASE; MICE; MICE, INBRED C3H; MOLECULAR SEQUENCE ANNOTATION; MUSCLES; SPECIFIC PATHOGEN-FREE ORGANISMS; TRANSCRIPTION, GENETIC;

EID: 84885442604     PISSN: 15303667     EISSN: 15577759     Source Type: Journal    
DOI: 10.1089/vbz.2012.1189     Document Type: Article

References (100)

1. Abruzzo LV, Lee KY, Fuller A, Silverman A, et al. Validation of oligonucleotide microarray data using microfluidic low-density arrays: A new statistical method to normalize real-Time RT-PCR data. Biotechniques 2005; 38:785-792
2. Adusumilli S, Booth CJ, Anguita J, Fikrig E. Passage through Ixodes scapularis ticks enhances the virulence of a weakly pathogenic isolate of Borrelia burgdorferi. Infect Immun 2010; 78:138-144
3. Anderton JM, Tokarz R, Thill CD, Kuhlow CJ, et al. Wholegenome DNA array analysis of the response of Borrelia burgdorferi to a bactericidal monoclonal antibody. Infect Immun 2004; 72:2035-2044
4. Armstrong AL, Barthold SW, Persing DH, Beck DS. Carditis in Lyme disease susceptible and resistant strains of laboratory mice infected with Borrelia burgdorferi. Am J Trop Med Hyg 1992; 47:249-258
5. Bachmann M, Horn K, Rudloff I, Goren I, et al. Early production of IL-22 but not IL-17 by peripheral blood mononuclear cells exposed to live Borrelia burgdorferi: The role of monocytes and interleukin-1. PLoS Pathogens 2010; 6:e1001144
6. Backenson PB, Coleman JL, Benach JL. Borrelia burgdorferi shows specificity of binding to glycosphingolipids. Infect Immun 1995; 63:2811-2817
7. Bankhead T, Chaconas G. The role of VlsE antigenic variation in the Lyme disease spirochete: Persistence through a mechanism that differs from other pathogens. Mol Microbiol 2007; 65:1547-1558
8. Barbour AG. Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med 1984; 57:521-525
9. Barthold SW. Lyme borreliosis. In: Nataro JP, Blaser MJ, Cunningham-Rundles S, eds. Persistent Bacterial Infection. Washington, DC: ASM Press, 2000:281-304
10. Barthold SW, De Souza MS, Janotka JL, Smith AL, et al. Chronic Lyme borreliosis in the laboratory mouse. Am J Pathol 1993; 143:959-971
11. Barthold SW, Hodzic E, Tunev S, Feng S. Antibody-mediated disease remission in the mouse model of lyme borreliosis. Infect Immun 2006; 74:4817-4825
12. Barthold SW, Cadavid D, Philipp MT. Animal models of borreliosis. In: Samuels DS, Radolf J, eds. Borrelia, Molecular Biology, Host Interaction and Pathogenesis. Norfolk, UK: Caister Academic Press, 2010:353-405
13. Belfaiza J, Postic D, Bellenger E, Baranton G, et al. Genomic fingerprinting of Borrelia burgdorferi sensu lato by pulsed-field gel electrophoresis. J Clin Microbiol 1993; 31:2873-2877
14. Belperron AA, Bockenstedt LK. Natural antibody affects survival of the spirochete Borrelia burgdorferi within feeding ticks. Infect Immun 2001; 69:6456-6462
15. Benhnia MR, Wroblewski D, Akhtar MN, Patel RA, et al. Signaling through CD14 attenuates the inflammatory response to Borrelia burgdorferi, the agent of Lyme disease. J Immunol 2005; 174:1539-1548
16. Bhide MR, Escudero R, Camafeita E, Gil H, et al. Complement factor H binding by different Lyme disease and relapsing fever Borrelia in animals and human. BMC Research Notes 2009; 2
17. Boerlin P, Peter O, Bretz AG, Postic D, et al. Population genetic analysis of Borrelia burgdorferi isolates by multilocus enzyme electrophoresis. Infect Immun 1992; 60:1677-1683
18. Brissette CA, Bykowski T, Cooley AE, Bowman A, et al. Borrelia burgdorferi RevA antigen binds host fibronectin. Infect immun 2009a; 77:2802-2812
19. Brissette CA, Verma A, Bowman A, Cooley AE, et al. The Borrelia burgdorferi outer-surface protein ErpX binds mammalian laminin. Microbiology 2009b; 155:863-872
20. Brooks CS, Hefty PS, Jolliff SE, Akins DR. Global analysis of Borrelia burgdorferi genes regulated by mammalian host-specific signals. Infect Immun 2003; 71:3371-3383
21. Bubeck-Martinez S. Immune evasion of the Lyme disease spirochetes. Front Biosci 2005; 10:873-878
22. Bustin SA. Absolute quantification of mRNA using real-Time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000; 25:169-193
23. Bustin SA, Beaulieu JF, Huggett J, Jaggi R, et al. MIQE precis: Practical implementation of minimum standard guidelines for fluorescence-based quantitative real-Time PCR experiments. BMC Mol Biol 2010; 11:74
24. Cabello FC, Godfrey HP, Newman SA. Hidden in plain sight: Borrelia burgdorferi and the extracellular matrix. Trends Microbiol 2007; 15:350-354
25. Cai JH, Deng S, Kumpf SW, Lee PA, et al. Validation of rat reference genes for improved quantitative gene expression analysis using low density arrays. Biotechniques 2007; 42:503-512
26. Christopherson JA, Munson EL, England DM, Croke CL, et al. Destructive arthritis in vaccinated interferon gamma-deficient mice challenged with Borrelia burgdorferi: Modulation by tumor necrosis factor alpha. Clin Diagnostic Lab Immunol 2003; 10:44-52
27. Ciotti P, Garuti A, Ballestrero A, Cirmena G, et al. Reliability and reproducibility of a RNA preamplification method for lowdensity array analysis from formalin-fixed paraffin-embedded breast cancer samples. Diagn Mol Pathol 2009; 18:112-118
28. Coburn J, Medrano M, Cugini C. Borrelia burgdorferi and its tropisms for adhesion molecules in the joint. Curr Opin Rheumatol 2002; 14:394-398
29. Coleman JL, Gebbia JA, Piesman J, Degen JL, Bugge TH, Benach JL. Plasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in mice. Cell 1997;89:1111-9
30. Cooke BM, Mohandas N, Cowman AF, Coppel RL. Cellular adhesive phenomena in apicomplexan parasites of red blood cells. Vet Parasitol 2005; 132:273-295
31. Crowley H, Huber BT. Host-Adapted Borrelia burgdorferi in mice expresses OspA during inflammation. Infect Immun 2003; 71:4003-4010
32. Dame TM, Orenzoff BL, Palmer LE, Furie MB. IFN-gamma alters the response of Borrelia burgdorferi-Activated endothelium to favor chronic inflammation. J Immunol 2007; 178:1172-1179
33. De Cremoux P, Bieche I, Tran-Perennou C, Vignaud S, et al. Inter-laboratory quality control for hormone-dependent gene expression in human breast tumors using real-Time reverse transcription-polymerase chain reaction. Endocr Relat Cancer 2004; 11:489-495
34. Defoe G, Coburn J. Delineation of Borrelia burgdorferi p66 sequences required for integrin alpha(IIb)beta(3) recognition. Infect Immun 2001; 69:3455-3459
35. Diterich I, Rauter C, Kirschning CJ, Hartung T. Borrelia burgdorferi-induced tolerance as a model of persistence via immunosuppression. Infect Immun 2003; 71:3979-3987
36. Dubytska L, Godfrey HP, Cabello FC. Borrelia burgdorferi ftsZ plays a role in cell division. J Bacteriol 2006; 188:1969-1978
37. Fuchs R, Jauris S, Lottspeich F, Preac-Mursic V, et al. Molecular analysis and expression of a Borrelia burgdorferi gene encoding a 22 kDa protein (pC) in Escherichia coli. Mol Microbiol 1992; 6:503-509
38. Gautam A, Dixit S, Philipp MT, Singh SR, et al. Interleukin-10 alters effector functions of multiple genes induced by Borrelia burgdorferi in macrophages to regulate Lyme disease inflammation. Infect Immun 2011; 79:4876-4892
39. Gilmore RD, Jr., Mbow ML, Stevenson B. Analysis of Borrelia burgdorferi gene expression during life cycle phases of the tick vector Ixodes scapularis. Microbes Infect 2001; 3:799-808
40. Gilsbach R, Kouta M, Bonisch H, Bruss M. Comparison of in vitro and in vivo reference genes for internal standardization of real-Time PCR data. Biotechniques 2006; 40:173-177
41. Goulter AB, Harmer DW, Clark KL. Evaluation of low density array technology for quantitative parallel measurement of multiple genes in human tissue. BMC Genomics 2006; 7:34
42. Grab DJ, Givens C, Kennedy R. Fibronectin-binding activity in Borrelia burgdorferi. Biochim Biophys Acta 1998; 1407:135-145
43. Guo BP, Brown EL, Dorward DW, Rosenberg LC, et al. Decorinbinding adhesins from Borrelia burgdorferi. Mol Microbiol 1998; 30:711-723
44. Hodzic E, Feng S, Freet KJ, Borjesson DL, et al. Borrelia burgdorferi population kinetics and selected gene expression at the host-vector interface. Infect Immun 2002; 70:3382-3388
45. Hodzic E, Feng S, Freet KJ, Barthold SW. Borrelia burgdorferi population dynamics and prototype gene expression during infection of immunocompetent and immunodeficient mice. Infect Immun 2003; 71:5042-5055
46. Hodzic E, Tunev S, Feng S, Freet KJ, et al. Immunoglobulinregulated expression of Borrelia burgdorferi outer surface protein A in vivo. Infect Immun 2005; 73:3313-3321
47. Hovis KM, Tran E, Sundy CM, Buckles E, et al. Selective binding of Borrelia burgdorferi OspE paralogs to factor H and serum proteins from diverse animals: Possible expansion of the role of OspE in Lyme disease pathogenesis. Infect Immun 2006; 74:1967-1972
48. Huggett J, Dheda K, Bustin S, Zumla A. Real-Time RT-PCR normalisation; strategies and considerations. Genes Immun 2005; 6:279-284
49. Hyde JA, Seshu J, Skare JT. Transcriptional profiling of Borrelia burgdorferi containing a unique bosR allele identifies a putative oxidative stress regulon. Microbiology 2006; 152:2599-2609
50. Hyde JA, Trzeciakowski JP, Skare JT. Borrelia burgdorferi alters its gene expression and antigenic profile in response to CO2 levels. J Bacteriol 2007; 189:437-445
51. Koci J, Derdakova M, Peterkova K, Kazimirova M, et al. Borrelia afzelii gene expression in Ixodes ricinus (Acari: Ixodidae) ticks. Vector Borne Zoonotic Dis 2006; 6:296-304
52. Lazarus JJ, Meadows MJ, Lintner RE, Wooten RM. IL-10 deficiency promotes increased Borrelia burgdorferi clearance predominantly through enhanced innate immune responses. J Immunol 2006; 177:7076-7085
53. Lazarus JJ, Kay MA, McCarter AL, Wooten RM. Viable Borrelia burgdorferi enhances interleukin-10 production and suppresses activation of murine macrophages. Infect Immun 2008; 76: 1153-1162
54. Le Fleche A, Postic D, Girardet K, Peter O, et al. Characterization of Borrelia lusitaniae sp. nov. by 16S ribosomal DNA sequence analysis. Int J Syst Bacteriol 1997; 47:921-925
55. Leong JM, Wang H, Magoun L, Field JA, et al. Different classes of proteoglycans contribute to the attachment of Borrelia burgdorferi to cultured endothelial and brain cells. Infect Immun 1998; 66:994-999
56. Liang FT, Jacobs MB, Bowers LC, Philipp MT. An immune evasion mechanism for spirochetal persistence in Lyme borreliosis. J Exp Med 2002a; 195:415-422
57. Liang FT, Nelson FK, Fikrig E. DNA Microarray assessment of putative Borrelia burgdorferi lipoprotein genes. Infect Immun 2002b; 70:3300-3303
58. Liang FT, Nelson FK, Fikrig E. Molecular adaptation of Borrelia burgdorferi in the murine host. J Exp Med 2002c;196:275-80
59. Liang FT, Brown EL, Wang T, Iozzo RV, et al. Protective niche for Borrelia burgdorferi to evade humoral immunity. Am J Pathol 2004a; 165:977-985
60. Liang FT, Yan J, Mbow ML, Sviat SL, Gilmore RD, Mamula M, Fikrig E. Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses. Infect Immun 2004b; 72:5759-5767
61. Lien E, Sellati TJ, Yoshimura A, Flo TH, et al. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 1999; 274:33419-33425
62. Lu B, Xu J, Chen J, Yu J, et al. TaqMan low density array is roughly right for gene expression quantification in colorectal cancer. Clin Chim Acta 2008; 389:146-151
63. Malawista SE. Resolution of Lyme arthritis, acute or prolonged: A new look. Inflammation 2000; 24:493-504
64. Marconi RT, Garon CF. Development of polymerase chain reaction primer sets for diagnosis of Lyme disease and for species-specific identification of Lyme disease isolates by 16S rRNA signature nucleotide analysis. J Clin Microbiol 1992; 30:2830-2834
65. Miklossy J, Kasas S, Zurn AD, McCall S, et al. Persisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosis. J Neuroinflammation 2008; 5:40
66. Miller JC, Stevenson B. Borrelia burgdorferi erp genes are expressed at different levels within tissues of chronically infected mammalian hosts. Int J Med Microbiol 2006; 296(Suppl 40): 185-194
67. Miller JC, Narayan K, Stevenson B, Pachner AR. Expression of Borrelia burgdorferi erp genes during infection of non-human primates. Microb Pathog 2005; 39:27-33
68. Miller JC, Ma Y, Bian J, Sheehan KC, et al. A critical role for type I IFN in arthritis development following Borrelia burgdorferi infection of mice. J Immunol 2008; 181:8492-8503
69. Narasimhan S, Caimano MJ, Liang FT, Santiago F, et al. Borrelia burgdorferi transcriptome in the central nervous system of nonhuman primates. Proc Natl Acad Sci USA 2003; 100:15953-15958
70. Norris DE, Coburn J, Leong JM, Hu LT, et al. Pathobiology of Lyme disease borrelia. In: Samuels DS, Radolf J, eds. Borrelia: Molecular Biology, Host Interaction and Pathogenesis. Norfolk, UK: Caister Academic Press, 2010:295-325
71. Ojaimi C, Brooks C, Casjens S, Rosa P, et al. Profiling of temperature-induced changes in Borrelia burgdorferi gene expression by using whole genome arrays. Infect Immun 2003; 71:1689-1705
72. Pal U, Fikrig E. Adaptation of Borrelia burgdorferi in the vector and vertebrate host. Microbes Infect 2003; 5:659-666
73. Pal U, Wang P, Bao F, Yang X, et al. Borrelia burgdorferi basic membrane proteins A and B participate in the genesis of Lyme arthritis. J Exp Med 2008; 205:133-141
74. Palmer GH, Bankhead T, Lukehart SA. Nothing is permanent but change-Antigenic variation in persistent bacterial pathogens. Cell Microbiol 2009; 11:1697-1705
75. Parveen N, Leong JM. Identification of a candidate glycosaminoglycan- binding adhesin of the Lyme disease spirochete Borrelia burgdorferi. Mol Microbiol 2000; 35:1220-1234
76. Parveen N, Cornell KA, Bono JL, Chamberland C, et al. Bgp, a secreted glycosaminoglycan-binding protein of Borrelia burgdorferi strain N40, displays nucleosidase activity and is not essential for infection of immunodeficient mice. Infect Immun 2006; 74:3016-3020
77. Pfaffl MW. A new mathematical model for relative quantification in real-Time RT-PCR. Nucleic Acids Res 2001; 29:e45
78. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-Time PCR. Nucleic Acids Res 2002; 30:e36
79. Pierce BA. The Genetic Code and Translation. In: Genetics: A Conceptual Approach. New York: W.H. Freeman & Company, 2008:395-424
80. Postic D, Assous M, Belfaiza J, Baranton G. Genetic diversity of borrelia of Lyme borreliosis. Wien Klin Wochenschr 1996; 108:748-751
81. Postic D, Ras NM, Lane RS, Hendson M, et al. Expanded diversity among Californian borrelia isolates and description of Borrelia bissettii sp. nov. (formerly Borrelia group DN127). J Clin Microbiol 1998; 36:3497-3504
82. Probert WS, Johnson BJ. Identification of a 47 kDa fibronectinbinding protein expressed by Borrelia burgdorferi isolate B31. Mol Microbiol 1998; 30:1003-1015
83. Radonic A, Thulke S, Mackay IM, Landt O, et al. Guideline to reference gene selection for quantitative real-Time PCR. Biochem Biophys Res Commun 2004; 313:856-862
84. Revel AT, Talaat AM, Norgard MV. DNA microarray analysis of differential gene expression in Borrelia burgdorferi, the Lyme disease spirochete. Proc Natl Acad Sci USA 2002; 99: 1562-1567
85. Rupprecht TA, Plate A, Adam M, Wick M, et al.The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis. J Neuroinflammation 2009; 6:42
86. Sanchez-Espiridion B, Sanchez-Aguilera A, Montalban C, Martin C, et al. A TaqMan low-density array to predict outcome in advanced Hodgkins lymphoma using paraffin-embedded samples. Clin Cancer Res 2009; 15:1367-1375
87. Schutzer SE, Fraser-Liggett CM, Casjens SR, Qiu WG, et al. Whole-genome sequences of thirteen isolates of Borrelia burgdorferi. J Bacteriol 2011; 193:1018-1020
88. Seemanapalli SV, Xu Q, McShan K, Liang FT. Outer surface protein C is a dissemination-facilitating factor of Borrelia burgdorferi during mammalian infection. PLoS One 2010; 5:e15830
89. Shin JJ, Strle K, Glickstein LJ, Luster AD, et al. Borrelia burgdorferi stimulation of chemokine secretion by cells of monocyte lineage in patients with Lyme arthritis. Arthritis Res Ther 2010; 12:R168
90. Sjowall J, Fryland L, Nordberg M, Sjogren F, et al. Decreased Th1-Type inflammatory cytokine expression in the skin is associated with persisting symptoms after treatment of erythema migrans. PLoS One 2011; 6:e18220
91. Steg A, Wang W, Blanquicett C, Grunda JM, et al. Multiple gene expression analyses in paraffin-embedded tissues by TaqMan low-density array: Application to hedgehog and Wnt pathway analysis in ovarian endometrioid adenocarcinoma. J Mol Diagn 2006; 8:76-83
92. Strle K, Drouin EE, Shen S, Khoury JE, et al. Borrelia burgdorferi stimulates macrophages to secrete higher levels of cytokines and chemokines than Borrelia afzelii or Borrelia garinii. J Infect Dis 2009; 200:1936-1943
93. Tokarz R, Anderton JM, Katona LI, Benach JL. Combined effects of blood and temperature shift on Borrelia burgdorferi gene expression as determined by whole genome DNA array. Infect Immun 2004; 72:5419-5432
94. Vandecasteele SJ, Peetermans WE, Merckx R, Van Eldere J. Quantification of expression of Staphylococcus epidermidis housekeeping genes with Taqman quantitative PCR during in vitro growth and under different conditions. J Bacteriol 2001; 183:7094-7101
95. Verma A, Brissette CA, Bowman A, Stevenson B. Borrelia burgdorferi BmpA is a laminin-binding protein. Infect Immun 2009; 77:4940-4946
96. Wang G, van Dam AP, Spanjaard L, Dankert J. Molecular typing of Borrelia burgdorferi sensu lato by randomly amplified polymorphic DNA fingerprinting analysis. J Clin Microbiol 1998; 36:768-776
97. Weening EH, Parveen N, Trzeciakowski JP, Leong JM, et al. Borrelia burgdorferi lacking DbpBA exhibits an early survival defect during experimental infection. Infect Immun 2008; 76:5694-5705
98. Wilske B, Busch U, Fingerle V, Jauris-Heipke S, et al. Immunological and molecular variability of OspA and OspC. Implications for Borrelia vaccine development. Infection 1996; 24:208-212
99. Xu Y, Johnson RC. Analysis and comparison of plasmid profiles of Borrelia burgdorferi sensu lato strains. J Clin Microbiol 1995; 33:2679-2685
100. Zambrano MC, Beklemisheva AA, Bryksin AV, Newman SA, et al. Borrelia burgdorferi binds to, invades, and colonizes native type I collagen lattices. Infect Immun 2004; 72:3138-3146